These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 27933339)
21. Antiosteoporotic activity of Saururus chinensis extract in ovariectomized rats. Sung MJ; Davaatseren M; Hur HJ; Kim HJ; Ryu SY; Choi YH; Cha MR; Kwon DY Phytother Res; 2012 Aug; 26(8):1182-8. PubMed ID: 22821855 [TBL] [Abstract][Full Text] [Related]
22. Dose-dependent enhancement of spinal fusion in rats with teriparatide (PTH[1-34]). Ming N; Cheng JT; Rui YF; Chan KM; Kuhstoss S; Ma YL; Sato M; Wang Y; Li G Spine (Phila Pa 1976); 2012 Jul; 37(15):1275-82. PubMed ID: 22281479 [TBL] [Abstract][Full Text] [Related]
23. Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate. Bitto A; Burnett BP; Polito F; Levy RM; Marini H; Di Stefano V; Irrera N; Armbruster MA; Minutoli L; Altavilla D; Squadrito F Br J Pharmacol; 2009 Apr; 156(8):1287-95. PubMed ID: 19302595 [TBL] [Abstract][Full Text] [Related]
24. Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study. Nishikawa A; Yoshiki F; Taketsuna M; Kajimoto K; Enomoto H Clin Interv Aging; 2016; 11():1653-1659. PubMed ID: 27895472 [TBL] [Abstract][Full Text] [Related]
25. Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine. Ren H; Shen G; Tang J; Qiu T; Zhang Z; Zhao W; Yu X; Huang J; Liang D; Yao Z; Yang Z; Jiang X Sci Rep; 2017 Sep; 7(1):10617. PubMed ID: 28878388 [TBL] [Abstract][Full Text] [Related]
26. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats. Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352 [TBL] [Abstract][Full Text] [Related]
27. Prevention of bone loss and improvement of pain-related behavior in hind limb-unloaded mice by administration of teriparatide and bisphosphonate. Miyamura G; Wakabayashi H; Nagao N; Kato S; Nakagawa T; Naito Y; Sudo A Mod Rheumatol; 2021 May; 31(3):733-742. PubMed ID: 32646253 [TBL] [Abstract][Full Text] [Related]
28. Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment? Correa CB; Camargos GV; Chatterjee M; Mesquita MF; Del Bel Cury AA; Naert I; Duyck J; Vandamme K Osteoporos Int; 2017 Apr; 28(4):1287-1293. PubMed ID: 27921147 [TBL] [Abstract][Full Text] [Related]
29. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis. Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256 [TBL] [Abstract][Full Text] [Related]
30. Oral alendronate can suppress bone turnover but not fracture in kidney transplantation recipients with hyperparathyroidism and chronic kidney disease. Yamamoto S; Suzuki A; Sasaki H; Sekiguchi-Ueda S; Asano S; Shibata M; Hayakawa N; Hashimoto S; Hoshinaga K; Itoh M J Bone Miner Metab; 2013 Jan; 31(1):116-22. PubMed ID: 23076292 [TBL] [Abstract][Full Text] [Related]
31. Skeletal and mineral metabolic effects of risedronate in a rat model of high-turnover renal osteodystrophy. Ishida H; Komaba H; Hamano N; Yamato H; Sawada K; Wada T; Nakamura M; Fukagawa M J Bone Miner Metab; 2020 Jul; 38(4):501-510. PubMed ID: 32140785 [TBL] [Abstract][Full Text] [Related]
32. Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or Teriparatide. Saag KG; Agnusdei D; Hans D; Kohlmeier LA; Krohn KD; Leib ES; MacLaughlin EJ; Alam J; Simonelli C; Taylor KA; Marcus R Arthritis Rheumatol; 2016 Sep; 68(9):2122-8. PubMed ID: 27111239 [TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective. Boonen S; Marin F; Mellstrom D; Xie L; Desaiah D; Krege JH; Rosen CJ J Am Geriatr Soc; 2006 May; 54(5):782-9. PubMed ID: 16696744 [TBL] [Abstract][Full Text] [Related]
34. Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism. Li X; Yu L; Asuncion F; Grisanti M; Alexander S; Hensley K; Han CY; Niu QT; Dwyer D; Villasenor K; Stolina M; Dean C; Ominsky MS; Ke HZ; Tomlinson JE; Richards WG Bone; 2017 Dec; 105():163-172. PubMed ID: 28867373 [TBL] [Abstract][Full Text] [Related]
35. Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body. Chevalier Y; Quek E; Borah B; Gross G; Stewart J; Lang T; Zysset P Bone; 2010 Jan; 46(1):41-8. PubMed ID: 19800436 [TBL] [Abstract][Full Text] [Related]
36. The effects of combination of alendronate and human parathyroid hormone(1-34) on bone strength are synergistic in the lumbar vertebra and additive in the femur of C57BL/6J mice. Johnston S; Andrews S; Shen V; Cosman F; Lindsay R; Dempster DW; Iida-Klein A Endocrinology; 2007 Sep; 148(9):4466-74. PubMed ID: 17569757 [TBL] [Abstract][Full Text] [Related]
37. Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model. Saito M; Shiraishi A; Ito M; Sakai S; Hayakawa N; Mihara M; Marumo K Bone; 2010 Apr; 46(4):1170-9. PubMed ID: 20026440 [TBL] [Abstract][Full Text] [Related]
38. Cortical and trabecular bone are equally affected in rats with renal failure and secondary hyperparathyroidism. Bajwa NM; Sanchez CP; Lindsey RC; Watt H; Mohan S BMC Nephrol; 2018 Feb; 19(1):24. PubMed ID: 29394885 [TBL] [Abstract][Full Text] [Related]
39. Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration. Miller PD; McCarthy EF Semin Arthritis Rheum; 2015 Apr; 44(5):477-482. PubMed ID: 25312241 [TBL] [Abstract][Full Text] [Related]
40. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies. Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]